Hugh Greville

1.5k total citations
40 papers, 1.2k citations indexed

About

Hugh Greville is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Emergency Medical Services. According to data from OpenAlex, Hugh Greville has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Emergency Medical Services. Recurrent topics in Hugh Greville's work include Cystic Fibrosis Research Advances (20 papers), Neonatal Respiratory Health Research (6 papers) and Respiratory Support and Mechanisms (5 papers). Hugh Greville is often cited by papers focused on Cystic Fibrosis Research Advances (20 papers), Neonatal Respiratory Health Research (6 papers) and Respiratory Support and Mechanisms (5 papers). Hugh Greville collaborates with scholars based in Australia, United States and United Kingdom. Hugh Greville's co-authors include Kevin E. Finucane, Anthony De Soyza, David J. Serisier, John Kolbe, Andrew T. Thornton, Peter Reimnitz, B Hampel, Philip J. Thompson, Tobias Welte and Igor Gonda and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Journal of Applied Physiology.

In The Last Decade

Hugh Greville

39 papers receiving 1.1k citations

Peers

Countries citing papers authored by Hugh Greville

Since Specialization

Citations

This map shows the geographic impact of Hugh Greville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Greville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Greville more than expected).

Fields of papers citing papers by Hugh Greville

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh Greville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Greville. The network helps show where Hugh Greville may publish in the future.

Co-authorship network of co-authors of Hugh Greville

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh Greville. A scholar is included among the top collaborators of Hugh Greville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh Greville. Hugh Greville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis 2019 ·Frontiers in Pharmacology ·André Schultz, Julie Marsh, Benjamin R. Saville, Richard Norman, Peter G. Middleton, Hugh Greville, M. Bellgard, Scott Berry, Tom Snelling	8
2	Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease 2019 ·Journal of Cystic Fibrosis ·(unknown), Daniel Barker, (unknown), Lucy Burr, Hugh Greville, (unknown), Peter G. Middleton, Claire Wainwright, Douglas J. Dorahy, Peter Wark	14
3	Airway clearance by exercising in mild cystic fibrosis (ACE-CF): A feasibility study 2018 ·Respiratory Medicine ·Nathan Ward, Kathy Stiller, Hilary Rowe, Scott Morrow, Judith Morton, Hugh Greville, Anne E. Holland	13
4	Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial 2013 ·Thorax ·David J. Serisier, Diana Bilton, Anthony De Soyza, Philip J. Thompson, John Kolbe, Hugh Greville, David Cipolla, (unknown), Igor Gonda, (unknown)	181
5	Gastric Emptying, Incretin Hormone Secretion, and Postprandial Glycemia in Cystic Fibrosis—Effects of Pancreatic Enzyme Supplementation 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Paul Kuo, Julie E. Stevens, Antonietta Russo, A. Maddox, Judith M. Wishart, Karen L. Jones, Hugh Greville, David J. Hetzel, Ian Chapman, Michael Horowitz, Christopher K. Rayner	75
6	Nonvolumetric Echocardiographic Indices of Right Ventricular Systolic Function: Validation with Cardiovascular Magnetic Resonance and Relationship with Functional Capacity 2011 ·Echocardiography ·Darryl P. Leong, Suchi Grover, Payman Molaee, Adhiraj Chakrabarty, Mitra Shirazi, Yi Cheng, (unknown), Rebecca Perry, Hugh Greville, Majo Joseph, Joseph B. Selvanayagam	47
7	Efficacy and safety of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis 2011 ·European Respiratory Journal ·Robert C. Wilson, Tobias Welte, Eva Polverino, Anthony De Soyza, Hugh Greville, Anne E. O’Donnell, Jeff Alder, Peter Reimnitz, B Hampel	5
8	Antimicrobial efficacy of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis 2011 ·European Respiratory Journal ·Jeff Alder, Robert C. Wilson, Tobias Welte, Eva Polverino, Anthony De Soyza, Hugh Greville, Anne O’Donnell, Peter Reimnitz, B Hampel	4
9	What is the best method for measuring renal function in adults and children with cystic fibrosis? 2010 ·Journal of Cystic Fibrosis ·(unknown), Hugh Greville, Kingsley Coulthard, (unknown)	15
10	Renal dysfunction in cystic fibrosis: Is there cause for concern? 2009 ·Pediatric Pulmonology ·(unknown), Hugh Greville, Kingsley Coulthard, Christopher J Doecke	14
11	Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF) 2008 ·Clinical Endocrinology ·(unknown), Hugh Greville, Peter R. Ebeling, Susannah King, Tom Kotsimbos, (unknown), (unknown), Duncan J. Topliss, Janet Warner, John Wilson	31
12	Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new? 2008 ·Internal Medicine Journal ·(unknown), Scott C. Bell, Hugh Greville, C. J. Doecke	12
13	Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports 2006 ·Internal Medicine Journal ·(unknown), David Gillis, William Smith, Pravin Hissaria, Hugh Greville, Chen Au Peh	31
14	ABS55: A qualitative study of patient perceptions of home oxygen therapy 2006 ·Primary Care Respiratory Journal ·Alan Crockett, Anne Wilson, Ral Antic, Hugh Greville	1
15	Nocardia asteroides Isolated from Three Patients with Cystic Fibrosis 2002 ·European Journal of Clinical Microbiology & Infectious Diseases ·Richard Lumb, Hugh Greville, James Martin, N Sangster, Mark Holmes	24
16	Corticosteroid induced osteoporosis. Guidelines for treatment. 2001 ·Deakin Research Online (Deakin University) ·P. N. Sambrook, Terrence Diamond, (unknown), M Fiatarone-Singh, Leon Flicker, Alastair H. MacLennan, Caryl Nowson, Sinéad M. O’Neill, Hugh Greville	20
17	Exercise-induced hypoxaemia in highly trained cyclists at 40% peak oxygen uptake 1999 ·European Journal of Applied Physiology ·Anthony J. Rice, (unknown), Christopher J. Gore, Andrew T. Thornton, (unknown), Hugh Greville, Mark Holmes, R Scicchitano	47
18	Expiratory flow limitation in dogs with regional changes in lung mechanical properties 1988 ·Journal of Applied Physiology ·Steven N. Mink, Hugh Greville, (unknown), Jason W.‐L. Eng	7
19	Pulmonary disease from exposure to an artificial aluminium silicate: further observations. 1988 ·Occupational and Environmental Medicine ·Arthur W. Musk, B.D. Beck, Hugh Greville, Joseph D. Brain, Dian E. Bohannon	3
20	Asthma and irreversible airflow obstruction. 1984 ·Thorax ·(unknown), Hugh Greville, Kevin E. Finucane	246

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact